{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:52:49Z","timestamp":1777470769501,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.biologicals.2008.08.003","type":"journal-article","created":{"date-parts":[[2008,10,13]],"date-time":"2008-10-13T06:22:28Z","timestamp":1223878948000},"page":"26-31","source":"Crossref","is-referenced-by-count":19,"title":["Virus inactivation in a factor VIII\/VWF concentrate treated using a solvent\/detergent procedure based on polysorbate 20"],"prefix":"10.1016","volume":"37","author":[{"given":"Peter L.","family":"Roberts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2008.08.003_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/(SICI)1099-1654(199603)6:1<25::AID-RMV162>3.0.CO;2-2","article-title":"Virus safety of plasma products","volume":"6","author":"Roberts","year":"1996","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.biologicals.2008.08.003_bib2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1054\/blre.2000.0129","article-title":"Reducing the risk of infection from plasma products: specific preventative strategies","volume":"14","author":"Burnouf","year":"2000","journal-title":"Blood Rev"},{"key":"10.1016\/j.biologicals.2008.08.003_bib3","unstructured":"Committee for Proprietary Medicinal Products. European Medicines Evaluation Agency: note for guidance on plasma-derived medicinal products. CPMP\/BWP\/269\/95 rev 3; 2001."},{"key":"10.1016\/j.biologicals.2008.08.003_bib4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1046\/j.1537-2995.1985.25686071422.x","article-title":"Inactivation of viruses in labile blood derivatives. I. Disruption of lipid-enveloped viruses by tri (n-butyl) phosphate detergent combinations","volume":"25","author":"Horowitz","year":"1985","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2008.08.003_bib5","first-page":"147","article-title":"Virus safety of solvent-detergent treated blood products","volume":"81","author":"Horowitz","year":"1993","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.biologicals.2008.08.003_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1423-0410.1984.tb00045.x","article-title":"Inactivation of hepatitis B and Hutchinson strain non-A, non-B viruses by exposure to Tween 80 and ether","volume":"46","author":"Prince","year":"1984","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2008.08.003_bib7","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0140-6736(86)91101-3","article-title":"Sterilisation of hepatitis and HTLV-III viruses by exposure to tri(n-butyl) phosphate and sodium cholate","volume":"i","author":"Prince","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2008.08.003_bib8","first-page":"191","article-title":"Affinity chromatography to remove viruses during preparation of plasma derivatives","volume":"81","author":"Lawrence","year":"1993","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.biologicals.2008.08.003_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/biol.1999.0236","article-title":"Resistance of vaccinia virus to inactivation by solvent\/detergent treatment of blood products","volume":"28","author":"Roberts","year":"2000","journal-title":"Biologicals"},{"issue":"Suppl. 10","key":"10.1016\/j.biologicals.2008.08.003_bib10","first-page":"137","article-title":"Virus inactivation by solvent\/detergent in Optivate\u00ae, a new high purity factor VIII concentrate with Von Willebrand factor (VWF)","volume":"3","author":"Walker","year":"2004","journal-title":"Haemophilia"},{"key":"10.1016\/j.biologicals.2008.08.003_bib11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0021-9258(18)57021-6","article-title":"Determination of serum protein by means of the Biuret reaction","volume":"177","author":"Gornall","year":"1949","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biologicals.2008.08.003_bib12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.1423-0410.2003.00275.x","article-title":"Effect of manufacturing process parameters on virus inactivation by solvent-detergent treatment in a high-purity factor IX concentrate","volume":"84","author":"Roberts","year":"2003","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2008.08.003_bib13","unstructured":"Committee for Proprietary Medicinal Products. European Medicines Evaluation Agency: note for guidance on virus validation studies. The design, contribution and interpretation of studies validating the inactivation and removal of viruses. CPMP\/BWP\/268\/95; 1996."},{"issue":"Suppl. 1","key":"10.1016\/j.biologicals.2008.08.003_bib14","article-title":"Inactivation of non-enveloped viruses by non-ionic detergent in the fibrinogen component of fibrin sealant","volume":"1","author":"Stagg","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"Suppl. 1","key":"10.1016\/j.biologicals.2008.08.003_bib15","article-title":"Purification and formulation of a dual viral-inactivated fibrinogen concentrate for use in a fibrin sealant","volume":"1","author":"Clemmitt","year":"2003","journal-title":"Thromb Haemost"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104510560800081X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104510560800081X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T10:35:47Z","timestamp":1631961347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104510560800081X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S104510560800081X"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2008.08.003","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}